Primary tumor levels of tissue inhibitor of metalloproteinases-1 are predictive of resistance to chemotherapy in patients with metastatic breast cancer. [electronic resource]
Producer: 20071128Description: 7054-8 p. digitalISSN:- 1078-0432
- Adult
- Aged
- Anthracyclines -- pharmacology
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Apoptosis -- drug effects
- Breast Neoplasms -- diagnosis
- Cyclophosphamide -- pharmacology
- Disease-Free Survival
- Drug Resistance, Neoplasm
- Female
- Fluorouracil -- pharmacology
- Follow-Up Studies
- Humans
- Methotrexate -- pharmacology
- Middle Aged
- Multivariate Analysis
- Predictive Value of Tests
- Sensitivity and Specificity
- Tissue Inhibitor of Metalloproteinase-1 -- biosynthesis
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.